Eppen_TracePCR_Dec24
  Editorial
 HEAVENS WILL NOT FALL   
 Wednesday, December 31, 2025 
 For the pharmaceutical companies with a turnover of less than Rs. 250 crore, time is ticking away fast to implement the Revised Schedule M. According to reports, a large number of MSME units, especially small and 
  Past Editorial...  
TODAY'S NEWS
18:00  [IST]Ultragenyx Pharma announces phase 3 Orbit & Cosmic results for setrusumab in osteogenesis imperfecta
17:00  [IST]Enveric Biosciences receives US patent entitled, “Substituted Ethylamine Fused Heterocyclic Mescaline Derivatives”
16:00  [IST]Establishment Labs Holdings submits Motiva implants to US FDA for approval in primary and revision breast reconstruction
15:00  [IST]WORK Medical’s subsidiary Hunan Saitumofei receives manufacturing approval for its Class II medical devices
14:00  [IST]SOFIE Biosciences doses first patient dosed in phase 3 trials of [18F]FAPI-74, a fluorine-18 labelled radiopharmaceutical targeting FAP for patients with GI cancers
13:00  [IST]US FDA grants 510(k) clearance to StimLabs’ Theracor, a first human umbilical cord-derived medical device sheet
more news >>
TOP NEWS
08:00  [IST]Almost 85% of overcharged amount claimed by NPPA yet to be recovered
08:00  [IST]TN DCA’s report exposes 364 safety violations as youngest Coldrif survivor returns home after 114 days
08:00  [IST]Ayush and herbal products exports decline 33% in October
08:00  [IST]Indian hospitals step up cyber defenses with advanced security strategies
08:00  [IST]India needs stronger regional healthcare systems to address infections, lifestyle related health issues: Experts
08:00  [IST]Unanswered questions loom as Pondicherry refers multi-crore counterfeit medicine racket to CBI and NIA
more news >>
YESTERDAY'S NEWS
18:00  [IST]Senhwa Biosciences aims at multi-billion dollar global market with CX-5461 combined with ADC “Blockbuster” therapy
17:00  [IST]Transcenta inks strategic collaboration and non-exclusive licensing pact with EirGenix to advance integrated continuous biomanufacturing and expand global access to affordable biologics
16:00  [IST]Diamyd Medical accelerates primary efficacy readout by 9 months in type 1 diabetes phase 3 trial following US FDA alignment and guidance
15:30  [IST]cGxP Lifeline conference 2025 themed ‘Defining Ethics, Elevating Quality Standards’ hosted in Mumbai
14:50  [IST]Aerolase’s advanced 1064 nm Nd:YAG laser platform shows positive results  for psoriasis
14:30  [IST]Lupin inks licensing agreement with Gan & Lee Pharmaceuticals for novel GLP-1 receptor agonist
more news >>
INTERVIEW  
Haryana DC targets 100% Schedule M compliance in MSME sector through risk-based audits and continuous training
Lalit Kumar Goel, State Drug Controller (SDC) of Haryana
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
  
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
                                                         
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram